Reuters Health Report

Click to View in Browser 04/18/2014 Obama argues healthcare law is working, rejects Republican criticism WASHINGTON (Reuters) - President Barack Obama mounted a vigorous effort on Thursday to show his signature healthcare law is working and dismissed Republican critics who are using flaws in Obamacare to campaign for ousting Democrats from the U.S. Congress in November. Mediterranean diet may slow diabetes progression NEW YORK (Reuters Health) - For people recently diagnosed with type 2 diabetes, eating lots of olive oil, fish and whole grains slows progression of the disease more than restricting fat, according to a new analysis. Forty years on, bullying takes its toll on health and wealth LONDON (Reuters) - The negative social, physical and mental health effects of childhood bullying are still evident nearly 40 years later, according to research by British psychiatrists. FDA warns common uterine fibroid surgery can spread undetected cancer (Reuters) - The U.S. Food and Drug Administration warned that a common surgical procedure used to remove uterine fibroids could spread undetected uterine cancer. About 12 million U.S. outpatients misdiagnosed annually : study (Reuters) - Roughly 12 million adults who visit U.S. doctors' offices and other outpatient settings, or one in 20, are misdiagnosed every year, a new study has found, and half of those errors could lead to serious harm. Free dermatology drug samples come at a cost NEW YORK (Reuters Health) - Dermatologists tend to prescribe more expensive medications when they also give their patients drug samples, according to a new U.S. study. Merck's ragweed pollen allergy drug gets U.S. approval (Reuters) - The U.S. Food and Drug Administration has approved Merck & Co's pollen allergy drug Ragwitek. Brutish and short? DNA 'switch' sheds light on Neanderthals NEW YORK (Reuters) - How can creatures as different in body and mind as present-day humans and their extinct Neanderthal cousins be 99.84 percent identical genetically? Info may prompt seniors to taper off sleeping pills NEW YORK (Reuters Health) - Older people are willing and able to get themselves off medications like sleeping pills once they're informed of the potential harms, according to a new Canadian study. UnitedHealth: New hepatitis C drug costs far more than forecast (Reuters) - UnitedHealth Group Inc, the largest U.S. health insurer, said it spent more than $100 million to cover a pricey new hepatitis C drug from Gilead Sciences Inc in its first three months on the market, an amount that was "multiple" times what it had expected. Related Video Titan Aerospace a sky-high platform for Google's internet ambitions Rubbee set to electrify cycling The latest Reuters articles on M&A, IPOs, private equity, hedge funds and regulatory updates delivered to your inbox each day. Register Today   A daily digest of breaking business news, coverage of the US economy, major corporate news and the financial markets. Register Today   » MORE NEWSLETTERS

- 3 Times Square New York, NY 10036 USA © Copyright 2010 Thomson Reuters Ensure delivery of Reuters Newsmails, add mail@nl.reuters.com to your address book. Details Subscribe to other Reuters newsletters. Unsubscribe from this newsletter. Follow us on Twitter Friend us on Facebook Forward to a friend